| With T2DM | No T2DM | P value |
---|---|---|---|
(n = 149) | (n = 289) |  | |
Male, n | 111 (75%) | 219 (76%) | 0.77 |
Age (years) | 54 ± 12 | 54 ± 13 | 0.64 |
BMI (kg/m2) | 24.5 ± 3.6 | 24.4 ± 4.1 | 0.92 |
SBP (mmHg) | 116 ± 19 | 116 ± 17 | 0.99 |
DBP (mmHg) | 76 ± 14 | 77 ± 13 | 0.53 |
NYHA class, n | Â | Â | 0.24 |
 I | 7 (5%) | 21 (7%) |  |
 II | 53 (36%) | 101 (35%) |  |
 III | 70 (47%) | 114 (39%) |  |
 IV | 19 (13%) | 53 (18%) |  |
Hypertension, n | 53 (36%) | 100 (35%) | 0.84 |
Atrial fibrillation, n | 43 (29%) | 75 (26%) | 0.52 |
LBBB, n | 17 (11%) | 35 (12%) | 0.83 |
Smoking, n | 73 (49%) | 136 (47%) | 0.70 |
Alcohol, n | 47 (32%) | 100 (35%) | 0.52 |
ACEI/ARB/ARNI, n | 127 (85%) | 247 (86%) | 0.95 |
β-blockers, n | 126 (85%) | 244 (84%) | 0.97 |
MRA, n | 116 (78%) | 221 (77%) | 0.75 |
Diuretics, n | 112 (75%) | 213 (74%) | 0.74 |
Digoxin, n | 40 (27%) | 69 (24%) | 0.50 |
LVEDV index (ml/m2) | 176 ± 64 | 177 ± 58 | 0.89 |
LVESV index (ml/m2) | 139 ± 60 | 138 ± 56 | 0.79 |
LVM index (g/m2) | 88 ± 28 | 86 ± 27 | 0.58 |
LVEF (%) | 24 ± 10 | 24 ± 10 | 0.85 |
RVEDV index (ml/m2) | 97 ± 37 | 96 ± 34 | 0.85 |
RVESV index (ml/m2) | 66 ± 36 | 64 ± 34 | 0.61 |
RVEF (%) | 36 ± 14 | 36 ± 14 | 0.64 |
LGE presence, n | 82 (55%) | 163 (56%) | 0.79 |
Native T1 (ms) | 1318 ± 81 | 1310 ± 73 | 0.24 |
ECV (%) | 32.9 ± 6.4 | 32.6 ± 6.2 | 0.67 |